Search for: "Long et al v. Fresenius USA, Inc. et al"
Results 1 - 5
of 5
Sorted by Relevance
|
Sort by Date
16 Apr 2020, 9:45 am
The court’s approach was originally solidified in Fresenius USA, Inc. v. [read post]
3 Dec 2013, 4:15 am
Oracle Corporation, et. al (TXWD). [read post]
20 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: England and Wales High Court holds employee-inventor entitled to ‘fair share’ compensation: Kelly and Chui v GE Healthcare Ltd (IP Spotlight) (Out-Law) (Managing Intellectual Property) (Law360) (IPKat) (IAM) USPTO roundtable on deferred examination – reports and analysis (Inventive Step) (Patent Docs)… [read post]
17 Mar 2020, 1:32 pm
For instance, when evaluating a company’s medical device recall strategy, the FDA considers several factors, including (but not limited to): Results of a health hazard evaluation assessing the extent of any harm done, to whom, for how long. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
